microdosed tirzepatide Microdose Microdosing tirzepatide is an emerging

HCG monotherapy has shown promise for men with symptomatic testosterone deficiency

Weeks 4-8: Peak side effect period

In Table 2, we evaluated the number of first-time NAION events, person-years at risk, incidence rates, and we performed a crude and a multivariable Cox proportional hazard regression adjusted for sex, age, marital status, duration of diabetes, hemoglobin A1c, estimated glomerular filtration rate, history of cardiovascular disease, use of insulin, use of cholesterol lowering medicine, and use of blood pressure lowering medicine

Peter Attia The Drive AMA episodes on GLP-1s: thoughtful deep dives into mechanisms, pros, and cons